Skip to content
10-Q

Quarterly Report

SOPHIRIS BIO INC.

0001437749-19-022154

← back to feed
Filed
Nov 8, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 1, 2019 34.47M sh
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$8.43M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$11.34M
Long Term Debt Q3 2019 · Sep 30, 2019 $3.09M
Long Term Debt Q3 2019 · Dec 31, 2018 $5.09M
Short Term Debt Q3 2019 · Sep 30, 2019 $2.67M
Short Term Debt Q3 2019 · Dec 31, 2018 $1.92M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $4.25M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $11M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $12.05M
Cash And Equivalents Q3 2019 · Dec 31, 2017 $16.09M
Stockholders Equity Q3 2019 · Sep 30, 2019 −$2.76M
Stockholders Equity Q3 2019 · Jun 30, 2019 −$2.38M
Stockholders Equity Q3 2019 · Dec 31, 2018 $1.74M
Stockholders Equity Q3 2019 · Sep 30, 2018 −$3.97M
Stockholders Equity Q3 2019 · Jun 30, 2018 −$1.36M
Stockholders Equity Q3 2019 · Dec 31, 2017 $7.65M
Current Liabilities Q3 2019 · Sep 30, 2019 $3.93M
Current Liabilities Q3 2019 · Dec 31, 2018 $4.97M
Total Liabilities Q3 2019 · Sep 30, 2019 $9.86M
Total Liabilities Q3 2019 · Dec 31, 2018 $11.46M
Current Assets Q3 2019 · Sep 30, 2019 $7.01M
Current Assets Q3 2019 · Dec 31, 2018 $13.2M
Total Assets Q3 2019 · Sep 30, 2019 $7.1M
Total Assets Q3 2019 · Dec 31, 2018 $13.2M
Sga Expense Q3 2019 · Sep 30, 2019 $1.39M
Sga Expense Q3 2019 · Sep 30, 2019 $3.86M
Sga Expense Q3 2019 · Sep 30, 2018 $1.16M
Sga Expense Q3 2019 · Sep 30, 2018 $3.49M
Rd Expense Q3 2019 · Sep 30, 2019 $738K
Rd Expense Q3 2019 · Sep 30, 2019 $3.38M
Rd Expense Q3 2019 · Sep 30, 2018 $1.8M
Rd Expense Q3 2019 · Sep 30, 2018 $8.72M
Net Income Q3 2019 · Sep 30, 2019 −$959K
Net Income Q3 2019 · Sep 30, 2019 −$5.48M
Net Income Q3 2019 · Sep 30, 2018 −$2.87M
Net Income Q3 2019 · Sep 30, 2018 −$12.3M
Capex Q3 2019 · Sep 30, 2018 $4K